Stockscreener 앱 받기
3.44
2.99%
0.10
Ironwood Pharmaceuticals Inc 주식(IRWD)의 최신 뉴스
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by KBC Group NV - Defense World
Principal Financial Group Inc. Has $3.03 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Pacer Advisors Inc. Grows Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
IRWDIronwood Pharmaceuticals, Inc.Latest Stock News & Market Updates - StockTitan
Ironwood Pharmaceuticals SVP sells shares for $44,884 - Investing.com India
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stake Lessened by Sumitomo Mitsui Trust Group Inc. - Defense World
Ironwood Pharmaceuticals SVP sells shares worth $21,868 By Investing.com - Investing.com South Africa
Ironwood Pharmaceuticals SVP sells shares worth $21,868 - Investing.com
Ironwood Pharmaceuticals SVP sells shares for $44,884 By Investing.com - Investing.com Canada
Ironwood Pharmaceuticals (IRWD) Stock Declines Despite Industry Gains - GuruFocus.com
Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down - MSN
Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates - MSN
Ironwood Pharmaceuticals, Inc. Announces Resignation of Andrew Davis as Senior Vice President and Chief Business Officer, Effective November 22, 2024 - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Ironwood Ph - GuruFocus.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $10.40 Consensus PT from Analysts - Defense World
GSA Capital Partners LLP Purchases 232,087 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference - Business Wire
Ironwood Pharmaceuticals executive resigns - Investing.com India
Ironwood Pharmaceuticals executive resigns By Investing.com - Investing.com UK
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results and Recent Business Performance - Defense World
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Lowered to “Buy” Rating by StockNews.com - Defense World
Creative Planning Increases Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to Buy at StockNews.com - MarketBeat
What is Leerink Partnrs’ Estimate for IRWD FY2024 Earnings? - Defense World
FY2024 Earnings Forecast for IRWD Issued By Leerink Partnrs - MarketBeat
Robeco Institutional Asset Management B.V. Raises Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Quarterly Earnings Results - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript - Insider Monkey
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highli - GuruFocus.com
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... - Yahoo Finance
Earnings call: Ironwood Pharmaceuticals reports robust LINZESS demand By Investing.com - Investing.com Canada
Ironwood: Q3 Earnings Snapshot - Houston Chronicle
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap DownTime to Sell? - MarketBeat
Ironwood Pharmaceuticals Q3 Earnings: Revenue Beats at $91.59M, EPS Misses at $0.02 - GuruFocus.com
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results - Business Wire
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Prev - GuruFocus.com
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
StockNews.com Upgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) to Strong-Buy - Defense World
Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com
Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength - Marketscreener.com
Vanguard Group Inc's Strategic Acquisition in Ironwood Pharmaceu - GuruFocus.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.com - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Emerald Advisers LLC Has $1.88 Million Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Where Are They Now? Ironwood Pharmaceuticals - Life Science Leader Magazine
Ironwood Pharmaceuticals (IRWD) Scheduled to Post Earnings on Thursday - MarketBeat
What Do Analysts Think About Ironwood Pharmaceuticals Inc’s (NASDAQ:IRWD) Future? - Stocks Register
Short Bowel Syndrome Market to Show Remarkable Growth Trends - openPR
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% HigherHere's What Happened - MarketBeat
Ironwood Pharmaceuticals Shares Rise 10% on Positive Results in Bowel Disease Study - MarketWatch
Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2 - Business Wire
Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews
Applied Therapeutics (NASDAQ:APLT) versus Ironwood Pharmaceuticals (NASDAQ:IRWD) Head-To-Head Analysis - Defense World
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call - Business Wire
3.66%
0.30%
자본화:
|
볼륨(24시간):